Javascript must be enabled to continue!
Evaluation of Anticoagulation Outcome among Patients Taking Warfarin: A Single-Center Experience, Northwest Ethiopia
View through CrossRef
Abstract
BackgroundWarfarin is a widely used oral anticoagulant in clinical practice. It is used to prevent arterial emboli in patients with atrial fibrillation, or prevent and treat venous thromboembolism. The efficacy and safety of warfarin depends on maintaining the INR within the therapeutic range. The proportion of time spent in the therapeutic INR range (TTR) is used to evaluate quality of anticoagulation control.MethodsA hospital-based cross sectional study was conducted between November 1, 2019 and October 31, 2020 at Cardiac and Hematology Clinic, University of Gondar hospital. A consecutive sampling method was used to recruit 338 study subjects. Proportion of time spent in the therapeutic range (TTR) was calculated using the Rosendaal’s linear interpolation method. TTR ≥65% was described as ‘optimal’ International Normalized Ratio (INR) control. The Data were entered into EPI Info version 4.4.1 and transported to SPSS version 20 for analysis. Logistic regression analysis was used to identify associated factors with optimal anticoagulation outcome (TTR ≥65%). P-values <0.05 were used to declare significant association.ResultA total of 338 study subjects were included in the study. The mean age of patients was 49 years. The majority of study participants attended formal education (79%) and were urban dwellers (57%). Atrial fibrillation was the commonest indication for warfarin therapy. One-third (33%) of study subjects achieved the desired INRs (INR=2.0-3.0), while about one-tenth (13%) of patients attained optimal INR control (TTR≥65%). There were no significant association of socio-demographic characteristics including age, gender, educational level and monthly income with optimal INR control (TTR ≥65%). Likewise, clinical characteristics including dose of warfarin, warfarin adherence, frequency of INR determination, other concomitant drug intake, co-existing comorbidities, consumption of green leafy vegetables and alcohol intake didn’t show significant association with optimal INR control (TTR≥65%).ConclusionInstitution-based validated protocol might be required to overcome the poor TTR level. ‘Anticoagulation (INR) clinic’ would be required to ‘scale-up’ INR control.
Title: Evaluation of Anticoagulation Outcome among Patients Taking Warfarin: A Single-Center Experience, Northwest Ethiopia
Description:
Abstract
BackgroundWarfarin is a widely used oral anticoagulant in clinical practice.
It is used to prevent arterial emboli in patients with atrial fibrillation, or prevent and treat venous thromboembolism.
The efficacy and safety of warfarin depends on maintaining the INR within the therapeutic range.
The proportion of time spent in the therapeutic INR range (TTR) is used to evaluate quality of anticoagulation control.
MethodsA hospital-based cross sectional study was conducted between November 1, 2019 and October 31, 2020 at Cardiac and Hematology Clinic, University of Gondar hospital.
A consecutive sampling method was used to recruit 338 study subjects.
Proportion of time spent in the therapeutic range (TTR) was calculated using the Rosendaal’s linear interpolation method.
TTR ≥65% was described as ‘optimal’ International Normalized Ratio (INR) control.
The Data were entered into EPI Info version 4.
4.
1 and transported to SPSS version 20 for analysis.
Logistic regression analysis was used to identify associated factors with optimal anticoagulation outcome (TTR ≥65%).
P-values <0.
05 were used to declare significant association.
ResultA total of 338 study subjects were included in the study.
The mean age of patients was 49 years.
The majority of study participants attended formal education (79%) and were urban dwellers (57%).
Atrial fibrillation was the commonest indication for warfarin therapy.
One-third (33%) of study subjects achieved the desired INRs (INR=2.
0-3.
0), while about one-tenth (13%) of patients attained optimal INR control (TTR≥65%).
There were no significant association of socio-demographic characteristics including age, gender, educational level and monthly income with optimal INR control (TTR ≥65%).
Likewise, clinical characteristics including dose of warfarin, warfarin adherence, frequency of INR determination, other concomitant drug intake, co-existing comorbidities, consumption of green leafy vegetables and alcohol intake didn’t show significant association with optimal INR control (TTR≥65%).
ConclusionInstitution-based validated protocol might be required to overcome the poor TTR level.
‘Anticoagulation (INR) clinic’ would be required to ‘scale-up’ INR control.
Related Results
Establishment of pharmacogenomic algorithm for predicting stable warfarin dose in Chinese patients
Establishment of pharmacogenomic algorithm for predicting stable warfarin dose in Chinese patients
Background
Genetic variants of cytochrome P450 2C9 (CYP2C9) and vitamin K epoxide reductase (VKORC1) are known to influence warfarin dose, but the effect of other...
Building a predictive model for warfarin dosing via machine learning
Building a predictive model for warfarin dosing via machine learning
Abstract
Background
Warfarin titration via International Normalised Ratio (INR) monitoring can be a challenge for patients on lo...
Establishing Warfarin Clinics for improved Anticoagulation Management in Ethiopia
Establishing Warfarin Clinics for improved Anticoagulation Management in Ethiopia
Warfarin is essential for preventing thromboembolic complications in patients with atrial fibrillation and prosthetic heart valves, who are at significant risk for stroke, systemic...
untitled protocol v1
untitled protocol v1
Background: Warfarin is an oral anticoagulant associated with adverse reaction drugs due to wide inter- and intra-individual dosage variability. Warfarin dosage has been related to...
The Effect of Anti-coagulation Dosage on the Outcome of Hospitalized COVID-19 Patients in Ethiopia: A multi-center retrospective cohort study
The Effect of Anti-coagulation Dosage on the Outcome of Hospitalized COVID-19 Patients in Ethiopia: A multi-center retrospective cohort study
Abstract
Background:
Studies have indicated that hospitalized COVID-19 patients benefit from anticoagulation therapy in terms of survival; however, there is an ongoing cont...
The Effect of Anti-coagulation Dosage on the Outcome of Hospitalized COVID-19 Patients in Ethiopia: A multi-center retrospective cohort study
The Effect of Anti-coagulation Dosage on the Outcome of Hospitalized COVID-19 Patients in Ethiopia: A multi-center retrospective cohort study
Abstract
Background:
Studies have indicated that hospitalized COVID-19 patients benefit from anticoagulation therapy in terms of survival; however, there is an ongoing cont...
Group-Based Trajectory Analysis for Long-Term Use of Warfarin Therapy in Atrial Fibrillation Patients
Group-Based Trajectory Analysis for Long-Term Use of Warfarin Therapy in Atrial Fibrillation Patients
Atrial fibrillation (AF) patients suffer a high risk of ischemic stroke and other thromboembolism (TE). Warfarin is a long-term oral medication and is effective in reducing TE for ...
Abstract WP98: Variability of Perioperative Anticoagulation Strategies in Patients With Atrial Fibrillation
Abstract WP98: Variability of Perioperative Anticoagulation Strategies in Patients With Atrial Fibrillation
Introduction:
In patients with atrial fibrillation (AFib) whose anticoagulation (AC) requires being held prior to non-emergent surgery, ischemic stroke is an unfortunat...

